© 2023 by The Antibody Society Korea. Proudly created with Wix.com

Oral Session 1   July 4    2:00pm - 5:00pm    6 speakers

Chairperson: Junho Chung, M.D., Ph.D., Seoul National University

2:00pm - 2:25pm 

PharmAbcine's bispecific antibodies and its innovation

Jin-San Yoo, Dr. rer. Nat, PharmAbcine, Inc.

2:25pm - 2:50pm 

CD80/IL2v dual checkpoint inhibitor for solid tumors 

Myoung Ho Jang, Ph.D., GI Innovation Inc.

2:50pm - 3:15pm 

Cancer immunotherapy targeting TNF receptor superfamily

Hyun-Bae Jie, Ph.D., Ambrx

3:15pm - 3:45pm 

Coffee Break & Poster Viewing 

3:45pm - 4:10pm 

Double immune check point antibodies for cancer immunotherapy

Young-Gyu Cho, Ph.D., Y-Biologics Inc.

4:10pm - 4:35pm 

A novel mucosal vaccine leads to longevity with beneficial health effects

Kyung A Cho, Ph.D., Chonnam National University Medical School

4:35pm - 5:00pm 

Therapeutic effects of novel Tau antibody for Alzheimer’s disease

Seung-Yong Yoon, M.D., Ph.D., University of Ulsan College of Medicine